NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
BackgroundRecent advances in proteomic profiling have enabled its use as a powerful approach in elucidating molecular mechanisms underlying Parkinson's disease, enabling the identification of disease-associated protein alterations and candidate biomarkers for diagnosis, progression, and therapeutic response.ObjectivesThe Accelerating Medicines Partnership® Parkinson's Disease (AMP PD) program is a public-private partnership between the National Institutes of Health (NIH), multiple biopharmaceutical and life sciences companies, and non-profit organizations, managed by the Foundation for National Institutes of Health (FNIH). The program aims to advance the molecular and clinical characterization of PD through deep, longitudinal profiling of patient data and biosamples, with the goal of identifying and validating diagnostic, prognostic, and progression biomarkers for PD.MethodsLongitudinal proteomic profiling, both targeted and untargeted, was performed on cerebrospinal fluid (CSF) and plasma samples. The resulting datasets are publicly accessible via the AMP® PD Knowledge Platform.ResultsThe proteomic datasets enable differential protein analyses and can be used to explore molecular alterations associated with PD progression and heterogeneity.ConclusionsThese studies contribute to the broader AMP PD initiative by providing the research community with a harmonized proteomics dataset. As part of the larger AMP PD data, this work provides the PD community with a harmonized and accessible proteomics dataset that can be utilized for discovery, hypothesis generation, and validation of users' own research. © 2026 Technome. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.